Published in J Neurochem on July 01, 2002
Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci (2004) 3.12
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology (2010) 1.25
Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol (2009) 1.00
Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci (2014) 0.98
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci (2009) 0.95
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res (2013) 0.90
Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol (2010) 0.83
Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm (Vienna) (2009) 0.83
Neuroprotective effects of lithium treatment following hypoxic-ischemic brain injury in neonatal rats. Childs Nerv Syst (2011) 0.80
Deguelin, a natural rotenoid, inhibits mouse myeloma cell growth in vitro via induction of apoptosis. Oncol Lett (2012) 0.79
Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines. Pharmacogenomics J (2016) 0.77
Regulating cytoplasmic calcium homeostasis can reduce aluminum toxicity in yeast. PLoS One (2011) 0.77
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. Parkinsons Dis (2011) 0.77
Investigating the protective effect of lithium against high glucose-induced neurotoxicity in PC12 cells: involvements of ROS, JNK and P38 MAPKs, and apoptotic mitochondria pathway. Cell Mol Neurobiol (2014) 0.76
Protective effects of nimodipine and lithium against aluminum-induced cell death and oxidative stress in PC12 cells. Iran J Basic Med Sci (2016) 0.75
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 5.70
Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature (2011) 5.01
Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol Psychiatry (2006) 2.83
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry (2004) 1.82
Smaller frontal gray matter volume in postmortem schizophrenic brains. Am J Psychiatry (2002) 1.80
Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton (2003) 1.76
Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci (2011) 1.61
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet (2006) 1.61
The significance of environmental factors in the etiology of Alzheimer's disease. J Alzheimers Dis (2002) 1.48
High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol (2006) 1.31
Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology (2003) 1.30
BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res (2002) 1.30
Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry (2005) 1.24
Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Arch Gen Psychiatry (2003) 1.19
Synthesis and structure-affinity relationships of new 4-(6-iodo-H-imidazo[1,2-a]pyridin-2-yl)-N-dimethylbenzeneamine derivatives as ligands for human beta-amyloid plaques. J Med Chem (2007) 1.09
Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biol Psychiatry (2005) 1.07
Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct (2008) 1.06
Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur J Neurosci (2003) 1.06
Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci (2012) 1.05
Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage. Cancer Res (2012) 0.96
Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J Neurosci Methods (2007) 0.95
Age-related differences in glucocorticoid receptor mRNA levels in the human brain. Neurobiol Aging (2006) 0.93
Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol (2003) 0.91
Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. J Neurosci Res (2003) 0.91
A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain. Brain Res Mol Brain Res (2005) 0.91
International year of Chemistry 2011. A guide to the history of clinical chemistry. Clin Chem (2011) 0.90
Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology (2004) 0.89
Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age. Hippocampus (2006) 0.89
Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Neurobiol Aging (2002) 0.89
Preen gland function in layer fowls: factors affecting morphology and feather lipid levels. Comp Biochem Physiol A Mol Integr Physiol (2004) 0.89
Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease. J Med Chem (2004) 0.88
Aluminum-induced dendritic pathology revisited: cytochemical and electron microscopic studies of rabbit cortical pyramidal neurons. Ann Clin Lab Sci (2002) 0.87
Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. J Alzheimers Dis (2006) 0.86
The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. Neurosci Lett (2002) 0.85
Peri-nuclear clustering of mitochondria is triggered during aluminum maltolate induced apoptosis. J Alzheimers Dis (2006) 0.85
Cyclosporin A inhibits Al-induced cytochrome c release from mitochondria in aged rabbits. J Alzheimers Dis (2001) 0.85
Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia. Int J Neurosci (2008) 0.85
Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem (2003) 0.85
Discordant changes in cortical TrkC mRNA and protein during the human lifespan. Eur J Neurosci (2005) 0.83
MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways. J Neuropathol Exp Neurol (2003) 0.83
GDNF regulates the A beta-induced endoplasmic reticulum stress response in rabbit hippocampus by inhibiting the activation of gadd 153 and the JNK and ERK kinases. Neurobiol Dis (2004) 0.83
A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. J Mass Spectrom (2006) 0.82
Evaluation of tissue collection for postmortem studies of bipolar disorder. Bipolar Disord (2008) 0.81
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biol Psychiatry (2002) 0.80
Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Acta Neuropathol (2002) 0.80
Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. Neurotoxicology (2004) 0.80
Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol (2008) 0.79
Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau. Brain Res Mol Brain Res (2003) 0.79
Changes in NMDA receptor subunit mRNAs and cyclophilin mRNA during development of the human hippocampus. Ann N Y Acad Sci (2003) 0.77
Fifty years of Clinical Chemistry, three pioneering editors. Clin Chem (2004) 0.77
Supplementation of the diet with silicic acid to reduce body burden of aluminum: a miracle cure or useless treatment for Alzheimer's disease? J Alzheimers Dis (2006) 0.75
Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease. J Med Chem (2007) 0.75
Evaluation of analytical methods and workflow performance of the Architect ci8200 integrated serum/plasma analyzer system. Clin Chim Acta (2005) 0.75